Cencora logo

Cencora AI Adoption Tracker

Last updated: April 30, 2026

3.4 Good

Overview

Cencora (formerly AmerisourceBergen) is deploying AI across multiple business functions to enhance operational efficiency and improve healthcare delivery[1]. The pharmaceutical distribution company has integrated AI into systematic literature reviews, achieving 81-83% concordance with human reviewers[2][3]. Cencora has partnered with Infinitus to automate benefit verification processes, with AI agents handling calls to payors and achieving 97.8% first-pass approval rates[4]. The company is also investing $1 billion through 2030 to build AI-enabled distribution centers featuring autonomous mobile robots and advanced automation technology[5]. Leadership emphasizes AI's transformative potential across the healthcare ecosystem while maintaining a human-in-the-loop approach[6].

AI Maturity Index

3.4 /5 Practitioner

Evidence high

  • AI deployed across benefit verification, literature reviews, and distribution operations [other]

Missing Evidence

  • Limited evidence of formal AI governance structure

Evidence medium

  • Leadership discusses AI transformation across healthcare ecosystem [corporate]

Missing Evidence

  • No evidence of formal AI training programs mentioned

Evidence high

  • 97.8% first-pass approval rates and 80% administrative staff time reduction [other]

Missing Evidence

  • All evidence present

Radar Comparison

Company Sector Avg

Peer Comparison: Cencora vs healthcare

Based on 66 companies in sector

Dimension Cencora Sector Avg Diff
Adoption 3.0 3.7 -0.7
Proficiency 3.0 3.5 -0.5
Impact 4.0 3.6 +0.4
Overall 3.4 3.6 -0.2

AI Hiring Signals

Cencora Job Postings Analysis

7.2%
AI Mention Rate
111
Jobs Sampled
8
AI-Related Jobs
High Confidence
Data Quality

Tech vs Non-Tech AI Requirements

Tech Roles (Engineering/Data) 9.7%
Non-Tech Roles 6.3%

Top Departments by AI Mention Rate

Marketing
16.7%
Engineering/Tech
12.5%
Product
9.1%

Analysis

AI skills are emerging across Cencora with 7.2% of all job postings mentioning AI. While tech roles lead at 9.7%, non-tech roles show modest AI requirements at 6.3%, with Marketing showing the highest AI emphasis at 16.7%.

View Sample Job Postings (8 sources)

Key Metrics

97.8%
Benefit verification first-pass approval rate
Source: https://www.infinitus.ai/case-studies/cencora-patient-services/
80%
Administrative staff time freed up
Source: https://www.infinitus.ai/case-studies/cencora-patient-services/
88-100%
AI screening sensitivity
Source: https://www.cencora.com/-/media/assets/events/2024-ispor-us-an-evaluation-of-the-rayyan-artificial-intelligence-tool-for-systematic-literature-rev.pdf
5
AI Initiatives
Source: Larridin Analysis

AI Initiatives

1

$1 Billion Distribution Network Investment

November 2025

Active

Major infrastructure investment including AI-enabled distribution centers

New facilities will feature robotic handling systems, artificial intelligence, and autonomous mobile robots for improved efficiency

2

AI in Pharmaceutical Distribution Routes

2025

Active

Implementation of AI for route optimization and supply chain efficiency

Predictive algorithms to maximize distribution routes with improvements of up to half an hour per route

Supply Chain
3

AI for Formulary Decision-Making

2025

Active

AI tools to boost productivity in healthcare decision-making processes

Focus on monograph preparation, research paper summarization, and evidence aggregation for formulary evaluations

4

Rayyan AI Tool for Literature Reviews

May 2024

Active

Evaluation of AI tools for systematic literature review screening

Achieved 88-100% sensitivity and 81-83% concordance with human reviewers across different study types

Frequently Asked Questions

Cencora uses AI for route optimization, benefit verification automation, warehouse robotics, and systematic literature reviews to improve efficiency across the pharmaceutical supply chain.

The system achieves 97.8% first-pass approval rates, frees up 80% of administrative staff time, and processes verification requests within 24 hours compared to an 8-day average.

Cencora announced a $1 billion investment through 2030 to expand and automate its U.S. distribution network with AI-enabled facilities and robotic systems.

Yes, Cencora uses AI tools like Rayyan for systematic literature reviews, achieving 81-83% concordance with human reviewers while significantly reducing time requirements.

Cencora maintains a 'human-in-the-loop' approach, using AI as an ally rather than replacement, with emphasis on quality, rigor, and maintaining human oversight in critical decisions.

Related Companies

About AI Tracker

AI Tracker is a research project by Larridin, the AI execution intelligence platform.

Methodology: We analyze earnings calls, press releases, partnership announcements, and product documentation. All assessments are based solely on publicly available information—no private customer data is used.

Maturity Scoring: Each dimension is rated on a 4-tier scale (Nascent → Emerging → Scaling → Leading) based on evidence from public sources. Industry averages are computed as the median across all tracked companies in the sector.

Update cadence: Every 2-3 weeks
Last updated: April 30, 2026